The Second Annual Health Innovation Day will focus on two main themes - Emerging Technology in Health and Public Health Initiatives with individual presenters from government and industry in both sessions along with comments from a panel of Subject Matter Experts. The day event will include a separate government and industry “Innovation” panel with government moderators, Lightning Round presentations on health innovative or unique...

MedStar Georgetown University Hospital’s Diabetic Limb Salvage Conference is a multidisciplinary team approach meeting that provides each member of the healthcare team with the education and resources needed to heal wounds and prevent amputations. It features a prominent international faculty that promotes the importance of a multispecialty approach in limb salvage. The course is designed for healthcare practitioners of all specialties a...

The American Council for Technology and Industry Advisory council (ACT-IAC) will have a half-day Healthcare Blockchain forum that will provide the attendees with a better understanding of where the healthcare sector is headed and/or what they have accomplished to date in regard to the Blockchain platform. Presentations will be provided by the Department of Health and Human Services (HHS) and its Operating Divisions (OPDIVs), Veterans Affairs (...

Don’t miss your opportunity to be part of the 51st Annual Spring Conference in Washington, DC. This is the ideal venue to showcase your work to a national audience, learn from the success of others, and cultivate new ideas. Sessions will cover: Family medicine advocacy/policyInterprofessional collaboration in practice and educationCreating and teaching in the patient-centered medical homeFamily medicine that achieves the Triple Aim: b...

The Health Innovation Day hosted by ACT-IAC will provide attendees with wide-range discussions around technology, management/processes, and policy constraints and enablers and constraints with innovation. These discussions will involve the entire healthcare community of government, industry, academia, professional societies, product firms, and private sector hospital systems and payers in collaborative discussions of different perspectives. To...

Course Description In the past decade, the treatment of peritoneal metastases has gained interest from oncologic communities around the world. During the 1990’s, the first pioneering centers began treating patients with hyperthermic intraperitoneal chemotherapy (HIPEC). Prior to HIPEC, patients were treated with palliative support and only guaranteed a few months to live. Today, if a patient with peritoneal metastases is provided with pr...

Washington D.C. is one of the areas hardest hit by HIV in the U.S., with an epidemic on par with some developing nations. In D.C., approximately 2.7% of the population is living with HIV (>1% is considered a ‘generalized epidemic’), and D.C. has the highest AIDS diagnosis rate of any state in the U.S. The Council of the District of Columbia has identified medical provider education as a critical need to help address HIV, and has...

TAT congresses are annual meetings on new molecular targets and innovative cancer therapeutics in the early phases of clinical development, supplemented by associated translational research. Add to these features the high scientific standards, informal atmosphere, and active participation by the world’s leading phase 1 investigators, and you will understand why the TAT Congress series has become the prime international drug development m...

Timely recognition and optimal treatment of the many life-threatening digestive disorders to be reviewed at this conference remain challenging in clinical practice, thereby presenting the risk of delayed recognition and effective treatment. These challenges are met with state-of-the-art laboratory testing and diagnostic imaging, transplantation and other surgical interventions, and adjunctive or independent medical therapies. Medical therapies...

Pancreatic cysts are being detected with increasing frequency due to advances, and rising use of, imaging technology. A recent study suggests that only 2% of cysts are malignant at diagnosis. Clinicians are faced with the task of identifying those cysts with high malignant potential as early as possible while limiting unnecessary surgery. Current guidelines take a very cautious approach that result in unnecessary morbidity. Newer testing modal...